Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![SlowBullHQ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1921671320108158976.png) SlowBull [@SlowBullHQ](/creator/twitter/SlowBullHQ) on x XX followers
Created: 2025-07-16 12:25:24 UTC

$JNJ Johnson & Johnson Q2 2025
Global healthcare leader in Pharmaceuticals & MedTech ๐Ÿฅ

Outperformed across the board: delivered mid-single-digit revenue growth and EPS above consensus; raised FY25 outlook on strong cash flow & FX tailwinds ๐Ÿ’ฐ๐Ÿ“Š

โ€ข Pharma: oncology led the way with robust growth & key pipeline catalysts ๐Ÿš€
โ€ข MedTech: record device sales in orthopaedics & surgery ๐Ÿฆฟ
โ€ข Consumer Health: resilient demand in skincare & wellness ๐Ÿงด
โ€ข Margins expanded thanks to cost discipline & efficiency gains ๐Ÿ“ˆ
โ€ข Returned significant capital via buybacks & dividend hike ๐Ÿ’ธ
โ€ข Continued momentum in emerging markets ๐ŸŒ

![](https://pbs.twimg.com/media/Gv-pH2SWkAAVpoF.jpg)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945459750579417210/c:line.svg)

**Related Topics**
[cash flow](/topic/cash-flow)
[eps](/topic/eps)
[quarterly earnings](/topic/quarterly-earnings)
[medtech](/topic/medtech)
[coins healthcare](/topic/coins-healthcare)
[$jnj](/topic/$jnj)
[johnson johnson](/topic/johnson-johnson)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/SlowBullHQ/status/1945459750579417210)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

SlowBullHQ Avatar SlowBull @SlowBullHQ on x XX followers Created: 2025-07-16 12:25:24 UTC

$JNJ Johnson & Johnson Q2 2025 Global healthcare leader in Pharmaceuticals & MedTech ๐Ÿฅ

Outperformed across the board: delivered mid-single-digit revenue growth and EPS above consensus; raised FY25 outlook on strong cash flow & FX tailwinds ๐Ÿ’ฐ๐Ÿ“Š

โ€ข Pharma: oncology led the way with robust growth & key pipeline catalysts ๐Ÿš€ โ€ข MedTech: record device sales in orthopaedics & surgery ๐Ÿฆฟ โ€ข Consumer Health: resilient demand in skincare & wellness ๐Ÿงด โ€ข Margins expanded thanks to cost discipline & efficiency gains ๐Ÿ“ˆ โ€ข Returned significant capital via buybacks & dividend hike ๐Ÿ’ธ โ€ข Continued momentum in emerging markets ๐ŸŒ

XX engagements

Engagements Line Chart

Related Topics cash flow eps quarterly earnings medtech coins healthcare $jnj johnson johnson stocks healthcare

Post Link

post/tweet::1945459750579417210
/post/tweet::1945459750579417210